Erudio Healtherudio.com
Clinical trial · no report yet · Phase not applicable
VALOR trial: what clinicians have said so far
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- NCT02984761 ↗
- Recruiting
- VA Office of Research and Development
- Focused size, estimated: 1–150 verified statements once built
We haven't built an HCP commentary report on VALOR yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on VALOR so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 3 posts on X, typically up to 13 once built |
The trial
ClinicalTrials.gov- Official title
- CSP #2005 - Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy Trial (VALOR)
- Phase
- Phase not applicable
- Status
- Recruiting
- Conditions
- Lung Neoplasm
- Interventions
- Stereotactic Radiotherapy; Anatomic Pulmonary Resection
- Arms
- Stereotactic radiotherapy · Experimental
- Surgery · Active comparator
- Enrollment
- 670 (estimated)
- Primary outcomes
- Overall Survival
- Sponsor
- VA Office of Research and Development
- Start
- Apr 13, 2017
- Primary completion
- Sep 30, 2032 (estimated)
- Results posted
- No
- Registry record
- NCT02984761 · updated Oct 23, 2026
Publications
linked from the registry- Moghanaki D, Karas T, Timmerman RD, Cameron RB, Ritter TA, Shi H, Leiner MK, Feng H, Skinner VL, Robin L, Odle C, Sindowski T, Snodgrass AJ, Huang GD, Reda DJ, Harpole DH; Veterans Affairs Lung Cancer Surgery or Stereotactic Radiotherapy Study Team. Protocol for the Veterans Affairs Cooperative Studies Program Study Number 2005: A Phase 3 Randomized Trial of Lung Cancer Surgery or Stereotactic Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer. CHEST Pulm. 2023 Oct 5;1(3):100024. doi: 10.1016/j.chpulm.2023.100024. eCollection 2023 Dec. PubMed 42548402
- Elbanna M, Shiue K, Edwards D, Cerra-Franco A, Agrawal N, Hinton J, Mereniuk T, Huang C, Ryan JL, Smith J, Aaron VD, Burney H, Zang Y, Holmes J, Langer M, Zellars R, Lautenschlaeger T. Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy. Clin Lung Cancer. 2021 May;22(3):e342-e359. doi: 10.1016/j.cllc.2020.05.024. Epub 2020 Jun 2. PubMed 32736936